Published in Toxicol Sci on January 09, 2015
Pulmonary health effects of air pollution. Curr Opin Pulm Med (2016) 0.85
Cardiac Ischemia Reperfusion Injury Following Instillation of 20 nm Citrate-capped Nanosilver. J Nanomed Nanotechnol (2015) 0.82
Evolution of silver nanoparticles in the rat lung investigated by X-ray absorption spectroscopy. J Phys Chem A (2014) 0.81
Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury. Part Fibre Toxicol (2016) 0.78
Barriers to inhaled gene therapy of obstructive lung diseases: A review. J Control Release (2016) 0.77
Aerosolized Silver Nanoparticles in the Rat Lung and Pulmonary Responses over Time. Toxicol Pathol (2016) 0.77
Size-Dependent Deposition, Translocation, and Microglial Activation of Inhaled Silver Nanoparticles in the Rodent Nose and Brain. Environ Health Perspect (2016) 0.75
Mechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune system. Part Fibre Toxicol (2017) 0.75
Pulmonary effects of inhalation of spark-generated silver nanoparticles in Brown-Norway and Sprague-Dawley rats. Respir Res (2016) 0.75
Use of Autometallography in Studies of Nanosilver Distribution and Toxicity. Int J Toxicol (2015) 0.75
Genetic determinants of susceptibility to silver nanoparticle-induced acute lung inflammation in mice. FASEB J (2017) 0.75
Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano (2008) 5.68
Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect (1994) 3.26
Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect (1992) 2.76
Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect (2001) 2.28
Generation of metal nanoparticles from silver and copper objects: nanoparticle dynamics on surfaces and potential sources of nanoparticles in the environment. ACS Nano (2011) 2.28
Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci (2008) 2.22
The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol (2008) 2.16
Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol (2014) 1.77
Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol (2007) 1.74
Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol (2008) 1.66
Use of coated silver nanoparticles to understand the relationship of particle dissolution and bioavailability to cell and lung toxicological potential. Small (2013) 1.62
Cellular response in naphthalene-induced Clara cell injury and bronchiolar epithelial repair in mice. Am J Physiol (1995) 1.61
Environmental transformations of silver nanoparticles: impact on stability and toxicity. Environ Sci Technol (2012) 1.59
The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol (2007) 1.56
Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol (2011) 1.52
Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev (2013) 1.49
Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol (2011) 1.35
Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog Histochem Cytochem (2006) 1.29
Intracellular uptake and toxicity of Ag and CuO nanoparticles: a comparison between nanoparticles and their corresponding metal ions. Small (2013) 1.26
Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol Lett (2012) 1.25
Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv (2010) 1.23
The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. Biomaterials (2009) 1.20
An improved apparatus for acute inhalation exposure of rodents to radioactive aerosols. Toxicol Appl Pharmacol (1973) 1.18
Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective. J R Soc Interface (2013) 1.13
Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous. ACS Nano (2012) 1.09
The stability of silver nanoparticles in a model of pulmonary surfactant. Environ Sci Technol (2013) 1.09
Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface. Part Fibre Toxicol (2013) 1.03
Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review. J Aerosol Med Pulm Drug Deliv (2013) 0.96
Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats. Nanotoxicology (2012) 0.96
Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles. Part Fibre Toxicol (2014) 0.95
Computational modeling of nanoscale and microscale particle deposition, retention and dosimetry in the mouse respiratory tract. Inhal Toxicol (2014) 0.95
Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation. Int J Nanomedicine (2012) 0.94
In vivo liberation of silver ions from metallic silver surfaces. Histochem Cell Biol (2009) 0.93
Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol Pathol (2012) 0.91
Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J Nanomedicine (2013) 0.90
Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles. Toxicol Res (2012) 0.90
Persistence of silver nanoparticles in the rat lung: Influence of dose, size, and chemical composition. Nanotoxicology (2014) 0.88
Pulmonary and cardiovascular responses of rats to inhalation of silver nanoparticles. J Toxicol Environ Health A (2013) 0.88
Evolution of silver nanoparticles in the rat lung investigated by X-ray absorption spectroscopy. J Phys Chem A (2014) 0.81
In vivo measurement of extravasation of silver nanoparticles into liver extracellular space by push-pull-based continuous monitoring system. Toxicol Lett (2014) 0.80
In vivo synthesis of nanomaterials in plants: location of silver nanoparticles and plant metabolism. Nanoscale Res Lett (2014) 0.80